© David Gray

Martin Shkreli, the notorious pharmaceutical boss who gained rights to a $13.50 malaria medication and then promptly raised its price to $750, has become the new CEO of cancer-treatment developer KaloBios, after buying out the company at fire-sale prices.

full article at RT

 

 

 

 

 

 

Advertisements